Organic Chemicals
Description
MDAI
EMAIL:kvnchem@gmail.com
Skype:kvnchem
5,6-Methylenedioxy-2-aminoindane (MDAI) is a drug developed in the 1990s
by a team led by David E. Nichols at Purdue University. It acts as a
non-neurotoxic and highly selective serotonin releasing agent (SSRA) in
vitro and produces mild entactogen effects in humans.
Medicines Intermediates 2-AI 4-FA
4-FMC 4-MEC
4-MEA 5-IAI
AMT 5_MeO_AMT
5_MeO_DMT BUTTYLONE
METHYLONE NRG-1
MDAI MDPV
M1-2 METH
PV1-2 AM694
AM-2201
JWH-018
JWH-019
JWH-030
JWH-071
JWH-073
JWH-081
JWH-122
JWH-147
JWH-200
JWH-203
JWH-210
JWH-250
JWH-307
5-Meo-AMT
αMT
AM-694
5-Meo-DMT
5-MeO-DIPT
AM-2201
ZZ-2
M3-4
PV1-2
NRG-1
MDAI
MDPV
ZZ-1
Methylone
METH
Butylone
RCS-4
2-AI
4-FA
4-FMC
4-MEC
M3-4
Read More
Wuhan yuancen gongchuang technology development Co,.Ltt
JWH-071
Address: 496# zhongshang road Wuhan Hubei China,
Wuhan, Hubei
China, 430064
Tel: 0086-27-88320827
Fax: 0086-27-88324877